HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Forum Kayastha Selected Research

eIF-4B

2/2022PARK2 regulates eIF4B-driven lymphomagenesis.
2/2022PARK2 regulates eIF4B-driven lymphomagenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Forum Kayastha Research Topics

Disease

3Neoplasms (Cancer)
02/2022 - 06/2015
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2022 - 02/2022

Drug/Important Bio-Agent (IBA)

2eIF-4BIBA
02/2022 - 02/2022
2Rituximab (Mabthera)FDA Link
02/2022 - 02/2022
2Mechanistic Target of Rapamycin Complex 1IBA
02/2022 - 02/2022
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2022 - 02/2022
2Doxorubicin (Adriamycin)FDA LinkGeneric
02/2022 - 02/2022
2Prednisone (Sone)FDA LinkGeneric
02/2022 - 02/2022
2Vincristine (Oncovin)FDA LinkGeneric
02/2022 - 02/2022
1andrographolideIBA
06/2015